JP Morgan Chase
LABD icon

JP Morgan Chase’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

JP Morgan Chase’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.6K Buy
+6,175
New +$83.1K ﹤0.01% 6441
2026
Q1 		– Sell
-11,250
Closed -$237K – 7732
2025
Q4 		$237K Buy
11,250
+4,447
+65% +$121K ﹤0.01% 5449
2025
Q3 		$275K Buy
6,803
+6,713
+7,459% +$389K ﹤0.01% 5342
2025
Q2 		$6.73K Buy
+90
New +$7.96K ﹤0.01% 6376
2021
Q2 		– Sell
-6
Closed -$1K – 6478
2021
Q1 		$1K Buy
+6
New +$1.16K ﹤0.01% 5981

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

JP Morgan Chase's LABD Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026: 6,175 shares worth $47.6K. The stake represents ﹤0.01% of the portfolio and ranks #6441 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in LABD as recently as Q4 2025.

JP Morgan Chase first reported a position in LABD in Q1 2021 and has held it in 5 quarters since. The position peaked at $275K in Q3 2025. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • JP Morgan Chase held 6,175 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $47.6K as of Q2 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF was a new JP Morgan Chase position in Q2 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6441 holding.
  • JP Morgan Chase first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2021 and has held it in 5 quarters since.
  • JP Morgan Chase's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $275K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.